Cargando…
Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
Hepatocellular carcinoma (HCC) is an aggressive and incurable cancer. Although understanding of the molecular pathogenesis of HCC has greatly advanced, therapeutic options for the disease remain limited. In this study, we demonstrated that SETD5 expression is positively associated with poor prognosi...
Autores principales: | Park, Mijin, Moon, Byul, Kim, Jong-Hwan, Park, Seung-Jin, Kim, Seon-Kyu, Park, Kihyun, Kim, Jaehoon, Kim, Seon-Young, Kim, Jeong-Hoon, Kim, Jung-Ae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385566/ https://www.ncbi.nlm.nih.gov/pubmed/35950456 http://dx.doi.org/10.14348/molcells.2022.0009 |
Ejemplares similares
-
Corrigendum to: Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
por: Park, Mijin, et al.
Publicado: (2022) -
Synergistic antitumor activity of sorafenib and MG149 in hepatocellular carcinoma cells
por: Moon, Byul, et al.
Publicado: (2022) -
Downregulation of ADAMTS3 Suppresses Stemness and Tumorigenicity in Glioma Stem Cell
por: Kim, Hyun‐Jin, et al.
Publicado: (2022) -
Hypoxia stabilizes SETDB1 to maintain genome stability
por: Park, Sungryul, et al.
Publicado: (2023) -
KDM3A regulates Slug expression to promote the invasion of MCF7 breast cancer cells in hypoxia
por: Ahn, Hyun-Jung, et al.
Publicado: (2020)